Cells for immunotherapy engineered for targeting CD38 antigen and for CD38 gene inactivation

• 收藏
• 分享

专利权人:

Cellectis

发明人:

Dusseaux, Mathilde

申请号：

AU2016307050

公开号：

AU2016307050A1

申请日:

2016.07.26

申请国别(地区):

AU

年份:

2018

代理人:

摘要：

Methods of developing genetically engineered immune cells for immunotherapy, which can be endowed with Chimeric Antigen Receptors targeting an antigen marker that is common to both the pathological cells and said CD38 immune by the fact that the genes encoding said markers are inactivated in said immune cells by a rare cutting endonuclease such as TALEN, Cas9 or argonaute.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/